Literature DB >> 3167367

Growth hormone response to clonidine after recovery in patients with endogenous depression.

P B Mitchell1, J A Bearn, T H Corn, S A Checkley.   

Abstract

The growth hormone response to clonidine was measured in ten drug-free recovered patients, seven of whom had previously been tested when endogenously depressed, and compared with the response in ten individually matched controls. In eight of the patients there was an impairment of the growth hormone response, despite clinical recovery, although the hypotensive effect of clonidine in these patients was normal. This is suggestive of a persisting abnormal alpha2-adrenoceptor function in forebrain regions after recovery from an episode of endogenous depression, and may represent a trait marker for this condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167367     DOI: 10.1192/bjp.152.1.34

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  Can drugs cause depression? A review of the evidence.

Authors:  S B Patten; E J Love
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

2.  A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation.

Authors:  J F Deakin; I Pennell; A J Upadhyaya; R Lofthouse
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression.

Authors:  S M Guinjoan; J L Bernabó; D P Cardinali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 4.  Neuroendocrine predictors of the evolution of depression.

Authors:  Fabrice Duval; Marie-Claude Mokrani; José Antonio Monreal Ortiz; Pierre Schulz; Christiane Champeval; Jean-Paul Macher
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

5.  Psychiatric morbidity in adults with hypopituitarism.

Authors:  S Lynch; S Merson; S A Beshyah; E Skinner; P Sharp; R G Priest; D G Johnston
Journal:  J R Soc Med       Date:  1994-08       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.